NC
HAE icon

Nitorum Capital’s Haemonetics HAE Stock Holding History

Nitorum Capital’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-402,100
Closed -$47.7M – 41
2020
Q4 		$47.7M Buy
402,100
+1,748
+0.4% +$188K 1.85% 29
2020
Q3 		$34.9M Buy
400,352
+4,717
+1% +$412K 1.55% 29
2020
Q2 		$35.4M Buy
395,635
+1,571
+0.4% +$159K 1.82% 23
2020
Q1 		$39.3M Buy
394,064
+113,478
+40% +$12.3M 3.04% 14
2019
Q4 		$32.2M Buy
280,586
+1,076
+0.4% +$130K 1.8% 24
2019
Q3 		$35.3M Sell
279,510
-151,300
-35% -$19.2M 2.05% 23
2019
Q2 		$51.8M Buy
430,810
+107,133
+33% +$10.5M 2.95% 16
2019
Q1 		$28.3M Buy
323,677
+77,429
+31% +$7.04M 1.87% 24
2018
Q4 		$24.6M Buy
246,248
+77,319
+46% +$8.12M 2.52% 16
2018
Q3 		$19.4M Sell
168,929
-397,860
-70% -$41.2M 2.16% 24
2018
Q2 		$50.8M Sell
566,789
-369,507
-39% -$31.2M 5.69% 4
2018
Q1 		$68.5M Sell
936,296
-26,531
-3% -$1.82M 7.53% 4
2017
Q4 		$55.9M Buy
962,827
+127,193
+15% +$6.7M 6.64% 5
2017
Q3 		$37.5M Buy
835,634
+249,874
+43% +$10.4M 6.21% 4
2017
Q2 		$23.1M Buy
585,760
+135,276
+30% +$5.56M 4.6% 8
2017
Q1 		$18.3M Buy
450,484
+37,362
+9% +$1.46M 4.78% 9
2016
Q4 		$16.6M Buy
413,122
+61,289
+17% +$2.31M 4.78% 9
2016
Q3 		$12.7M Buy
351,833
+56,911
+19% +$1.95M 5.13% 8
2016
Q2 		$8.55M Buy
294,922
+112,312
+62% +$3.39M 4.08% 11
2016
Q1 		$6.39M Buy
182,610
+11,387
+7% +$368K 3.31% 13
2015
Q4 		$5.52M Buy
+171,223
New +$5.55M 3.13% 14

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nitorum Capital's HAE Position: Q1 2021 in Review

Nitorum Capital sold out of Haemonetics (HAE) in Q1 2021, closing a stake of 402,100 shares — an estimated $47.7M sold.

Nitorum Capital first reported a position in HAE in Q4 2015 and held it in 21 quarters. The position peaked at $68.5M in Q1 2018. 296 funds tracked by Wall St. Rank hold HAE as of Q1 2021.

  • Nitorum Capital reported no remaining Haemonetics position as of Q1 2021 after selling out during the quarter.
  • Nitorum Capital sold 402,100 Haemonetics shares in Q1 2021, an estimated $47.7M.
  • Nitorum Capital first reported a position in Haemonetics in Q4 2015 and held it in 21 quarters.
  • Nitorum Capital's Haemonetics position peaked at $68.5M in Q1 2018.
  • 296 funds tracked by Wall St. Rank held Haemonetics as of Q1 2021.

Based on Nitorum Capital's 13F filing for Q1 2021, filed 17 May 2021.